Peptron, Inc. (087010.KQ)
KRW 98300.0
(-1.99%)
KRW 98300.0
(-1.99%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -773.61 KRW | -5.94% |
| 2022 | -730.25 KRW | -0.14% |
| 2021 | -729.24 KRW | 39.02% |
| 2020 | -1195.96 KRW | -8.91% |
| 2019 | -1098.13 KRW | -375.53% |
| 2018 | -230.93 KRW | 16.62% |
| 2017 | -276.97 KRW | -33.32% |
| 2016 | -207.75 KRW | 3.13% |
| 2015 | -214.47 KRW | 75.18% |
| 2014 | -864.00 KRW | -30.51% |
| 2013 | -662.00 KRW | 20.34% |
| 2012 | -831.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -398.18 KRW | -102.95% |
| 2024 Q1 | -196.11 KRW | -23.57% |
| 2023 Q4 | -158.70 KRW | 21.2% |
| 2023 Q1 | -194.49 KRW | 36.5% |
| 2023 Q3 | -201.39 KRW | 8.03% |
| 2023 Q2 | -218.97 KRW | -12.59% |
| 2023 FY | - KRW | -5.94% |
| 2022 Q4 | -306.27 KRW | -107.56% |
| 2022 Q3 | -147.56 KRW | 17.12% |
| 2022 Q2 | -178.04 KRW | -80.97% |
| 2022 Q1 | -98.38 KRW | 49.14% |
| 2022 FY | - KRW | -0.14% |
| 2021 Q3 | -207.49 KRW | -169.99% |
| 2021 Q1 | -251.48 KRW | 20.12% |
| 2021 FY | - KRW | 39.02% |
| 2021 Q2 | -76.85 KRW | 69.44% |
| 2021 Q4 | -193.43 KRW | 6.78% |
| 2020 Q1 | -239.00 KRW | 63.13% |
| 2020 FY | - KRW | -8.91% |
| 2020 Q4 | -314.84 KRW | -12.04% |
| 2020 Q3 | -281.00 KRW | 22.16% |
| 2020 Q2 | -361.00 KRW | -51.05% |
| 2019 Q3 | -381.00 KRW | -202.38% |
| 2019 Q2 | -126.00 KRW | 10.64% |
| 2019 FY | - KRW | -375.53% |
| 2019 Q1 | -141.00 KRW | -228.67% |
| 2019 Q4 | -648.29 KRW | -70.15% |
| 2018 Q1 | -107.00 KRW | -247.06% |
| 2018 Q3 | -38.00 KRW | -158.46% |
| 2018 FY | - KRW | 16.62% |
| 2018 Q4 | -42.90 KRW | -12.89% |
| 2018 Q2 | 65.00 KRW | 160.75% |
| 2017 Q3 | -122.00 KRW | -35.56% |
| 2017 Q2 | -90.00 KRW | 57.94% |
| 2017 Q1 | -214.00 KRW | -37.9% |
| 2017 FY | - KRW | -33.32% |
| 2017 Q4 | -30.83 KRW | 74.73% |
| 2016 Q3 | -136.00 KRW | 3.55% |
| 2016 Q1 | -140.00 KRW | -8.85% |
| 2016 FY | - KRW | 3.13% |
| 2016 Q2 | -141.00 KRW | -0.71% |
| 2016 Q4 | -155.19 KRW | -14.11% |
| 2015 Q3 | -128.00 KRW | 28.09% |
| 2015 FY | - KRW | 75.18% |
| 2015 Q4 | -128.62 KRW | -0.48% |
| 2015 Q2 | -178.00 KRW | -50.85% |
| 2015 Q1 | -118.00 KRW | 0.0% |
| 2014 FY | - KRW | -30.51% |
| 2014 Q2 | -245.00 KRW | 15.81% |
| 2014 Q1 | -291.00 KRW | 0.0% |
| 2014 Q3 | -203.00 KRW | 17.14% |
| 2013 FY | - KRW | 20.34% |
| 2012 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 50.397% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | -164.835% |
| BINEX Co., Ltd. | 151.04 KRW | 612.189% |
| Bioneer Corporation | -410.19 KRW | -88.598% |
| Anterogen.Co.,Ltd. | -291.93 KRW | -164.998% |
| MEDIPOST Co., Ltd. | 287.00 KRW | 369.551% |
| CrystalGenomics, Inc. | -661.00 KRW | -17.036% |
| Helixmith Co., Ltd | -1543.76 KRW | 49.888% |
| Chabiotech Co.,Ltd. | -149.80 KRW | -416.429% |
| Medy-Tox Inc. | 1456.65 KRW | 153.109% |
| Amicogen, Inc. | -583.58 KRW | -32.563% |
| Genexine, Inc. | -1652.14 KRW | 53.175% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | -2308.499% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 70.188% |
| ALTEOGEN Inc. | -65.27 KRW | -1085.246% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 110.312% |
| SillaJen, Inc. | -179.98 KRW | -329.831% |
| JETEMA, Co., Ltd. | 783.21 KRW | 198.774% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 41.562% |
| Genomictree Inc. | -391.00 KRW | -97.854% |
| MedPacto, Inc. | -1664.87 KRW | 53.533% |
| D&D Pharmatech | 409.19 KRW | 289.059% |
| EASY BIO,Inc. | 455.00 KRW | 270.024% |
| GI Innovation, Inc. | -1285.69 KRW | 39.829% |